“Medicine and Law” is the eponymous project of the large-scale information portal of Faculty of Medical Law L.L.C. The main purpose of the section is informational legal support of healthcare professionals, healthcare organizers, medical and other institutions.

This is a unique knowledge base containing tens of thousands of various medical and legal materials on medical, labour and tax legislation, sanitary and epidemiological regime, administrative, civil and criminal law:

• legal opinions on topical and challenging issues of public healthcare;
• detailed analysis of specific legal situations;
• collection of healthcare normative legal acts in state regulation key areas;
• regular reviews of the most significant normative legal acts and case law of health care;
• videos and podcasts on hot-spot and critical health and law issues, and much more.

The most up-to-date data on genetic biomarkers, which are used to determine the prognosis of the disease and the optimal drugs’ selection.

Here contains the information on molecular genetic testing and immunohistochemical analysis, which are necessary to be carried out before prescription of different groups drugs:

• tyrosine kinase inhibitors,
• threonine / serine kinase inhibitors,
• monoclonal antibodies, etc.

The section continues to be filled.

Collection of relevant documents of the Ministry of Health regulating the diagnosis and treatment of oncological diseases is regularly updated.

Filters allow the user to quickly find the tumor you are looking for: tumors are grouped by location (head and neck tumors, endocrine tumors, etc.).

The PDF document can be downloaded, added to favourites or shared via instant messengers and social networks.

A quick reference guide provides  the information on over 800 treatment-associated adverse events, which are structured  by:

• definition,
• severity,
• patient management tactics appropriate for each degree of severity,
• MedDRA code.

For ease of searching, adverse events are grouped into 26 large groups according to MedDRA.

Calculator for evaluation of tumor clinical response to treatment upon RECIST 1.1, iRECIST and mRECIST criteria, and criteria beyond these scales.

Useful options:

• Creation a medical record and saving  diagnostic results,
• the ability to calculate the percentage change in the size of the measurable lesions and change in quantity of non-measurable lesions,
• interpretation of the results according to the criteria of the selected scale to assess the tumor response to treatment. If the case history does not fit the evaluating  criteria of the listed scales, the user can save all the data and get the information about changes in lesions without the result interpretation.

Tools, which are used for quick automated evaluation:

• the patient’s condition (for example, the G8 geriatric score),
• severity of the disease (for example, cirrhosis of the liver on the Child-Pugh score),
• prognosis and risk (e.g. Khorana score, APACHE II, IMDC)
• laboratory and instrumental parameters (for example, albumin-corrected calcium levels, PSA doubling time, GFR),
• anthropometric indicators,
• as well as for calculating and converting doses of drugs (carboplatin, glucocorticosteroids, opioid analgesics)

Reference information can help the user to interpret the results correctly.

Calculators for staging cancer upon the TNM and others accepted systems.

This is the most simple and convenient tool: the user just needs to answer certain questions about the tumor and treatment, then the stage is determined automatically.

Filters allow the user to quickly find the tumor you are looking for: tumors are grouped by location (head and neck tumors, endocrine tumors, etc.).

The section is focused primarily on morphologists, but it can also be useful for clinicians.

• General (reference) information:
  • about markers of epithelial, muscle, neuroendocrine, melanocytic, neuroglial and other differentiations,
  • markers for multipurpose staining,
  • markers that make it possible to diagnose anaplastic malignant tumors, distinguish between small round-cell basophilic and spindle-cell tumors, neuroendocrine and neuroectodermal tumors, etc.,
  • markers that make it possible to determine as accurately as possible the histogenesis of tumors, including metastases from an undetected primary focus,
  • criteria for interpreting the expression of estrogen and progesterone receptors, HER2 in breast cancer, EGFR, etc.
• Antibody alphabetical index. Brief characteristics of markers: type of expression (cytoplasmic, nuclear, etc.), Localization in normal tissues (control) and in tumors (with mention of the specification of use).
• Histological grade. Tables for assessing the aggressiveness of the tumor and its potential for malignancy for the pathomorphological conclusion.
• Differential diagnostics. The most up-to-date data on the immunoprofile of oncological diseases and its verification by immunohistochemical analysis. For the convenience of differential diagnostics, the data are presented in tables.

Varied in content and form, materials to test knowledge and study new methods of diagnostics and treatment of oncological diseases.

• Online testing (selection of treatment, survival forecast, metastasis risk assessment, side effects, etc.).
• Videos of past offline lectures and seminars and announcements of upcoming training events.
• Webinars (use of drugs and new surgeries, including conservative surgery).
• Tumor boards — live stream of a group of Russian and international experts’ discussion of case history with QA session. Announcements of the upcoming ones and the video records of past discussions are also available on the platform.

Perhaps, currently, it is the only press line which provides all the most significant events in the field of Russian oncology (last and future).

The user can filter events by:

• date,
• type: congress, conference, webinar, round table,
• field: head and neck tumors, CNS tumor, health care organization etc.,
• format: face-to-face or online,
• type: free or paid,
• CME credit,
• organizer etc.

Thematic magazines and newspapers collection:

• «Oncourology»,
• «Oncohematology»,
• «Head and neck tumors«
• «Tumors of female reproductive system «,
• «Advances in Molecular Oncology»,
• «Pelvic Surgery and Oncology»,
• «Oncological Coloproctology»,
• «Oncology Today»
• «Urology Today».

New issues come out regularly. The convenient structure of the section helps the user to find the desired article by the journal’s title, year, issue, and author’s surname.

Materials are available for download and share through social networks.

The news feed with updated and fresh information about oncology:

• reports of unique surgery cases performed by Russian and foreign scientists, the latest tools for diagnosing and treating cancer, innovative Internet resources for patients and doctors,
• articles about changes in the oncology drugs market, clinical guidelines review, vaccination for cancer patients and about other real issues and cases of clinical practice,
• news about FSES (Federal State Educational Standards), educational centers and trainings centers,
• experts opinion and comments on the cross-sectoral challenging issues from oncology, law and ethics field,
• notes on case law in the healthcare, changes in legal regulation of medical practice,
• latest statistics review and reports, mortality data and disease rate, quality of life estimation, healthcare costs data and scientist prognosis,
• professional oncology associations and charity organizations appeals,
• news about awards, prizes and grants, received by Russian scientists and also about new projects and funds and many other topics.

All posted news and information is verified.

The easy and convenient navigation system: the user can sort news by date, topic, and even by the tag, like “digitalization” or “COVID-19”.

News is available for easy sharing through social networks and adding to Google Calendar.